Establish a trusted basis for competitive analyses and statutory price certification with our up-to-date, industry leading database of pharmaceutical prices and reimbursement conditions across portfolios and countries. It provides vastly better coverage than alternative offerings.
What the three-part evidence-gathering method includes and how it helps to achieve both patient- & public health benefit and long-term economic success.
Akceso’s ‘Evidence-based Asset Valuation’ methodology Read More »
“I am really pleased with the outcome…. and seldom agree so quickly with
Great Feedback For Our Recent Pricing & Reimbursement Project Read More »
Akceso Advisors AG
Aeschengraben 29.
CH-4051 Basel, Switzerland
Verity IRP Master Tool
Verity Analogues Wizard
Verity Prices & Reimbursements
Verity MarketScout Rules & Regulations
Verity Managed Entry Agreements
Verity Tender Management
Verity Approvals
PRiMA Headlines
© 2011-2025 Akceso Advisors AG | Photos by Luca Gőbölyös & Thomas Bittera
Get in touch with us and schedule a demo.
Error: Contact form not found.
The PRiMA Headlines Newsletter provides a monthly overview of developments in Pricing, Reimbursement and Market Access across the globe. Since its launch in June 2015 we have covered more than 8,000 stories from over 160 countries.
